Antipsychotic drugs, like clozapine, can stabilise some schizophrenia symptoms, but they do not cure the illness and can cause severe side effects.
At UQ, a neuroscientist, a chemist and a psychiatrist have hit on a formulation that may revolutionise the treatment of schizophrenia. The research team, led by Professor Darryl Eyles and Dr Xiaoying Cui, are investigating a new delivery mode for clozapine, in the hope that it may be better tolerated by people living with schizophrenia and improve their quality of life.
In this engaging conversation, Darryl and Xiaoying discuss:
Treatment-resistant schizophrenia and the side-effects of clozapine
Collaborating with chemists to develop intranasal delivery
What they have found so far in preclinical studies
The potential impact of their research on schizophrenia treatment
Related resources
Epitranscriptomic regulation of striatal function: a new neurobiology of schizophrenia
Schizophrenia research at QBI